{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:21:21Z","timestamp":1793308881352,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.exppara.2022.108409","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T09:07:49Z","timestamp":1668762469000},"page":"108409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Immunological evaluation of a novel multi-antigenic DNA vaccine encoding SAG1, SAG3, MIC4, GRA5, GRA7, AMA1and BAG1 against Toxoplasma gondii in BALB\/c mice"],"prefix":"10.1016","volume":"244","author":[{"given":"Mohammadreza","family":"Alijani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnaz","family":"Saffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Yosefi Darani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9480-5330","authenticated-orcid":false,"given":"Mohammadreza","family":"Mahzounieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Fasihi- Ramandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Shakshi-Niaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sodabe","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ghaemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadegh","family":"Shirian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.exppara.2022.108409_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12419","article-title":"Evaluation of the immune response in BALB\/c mice induced by a novel DNA vaccine expressing GRA 14 against Toxoplasma gondii","volume":"39","author":"Ahmadpour","year":"2017","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.exppara.2022.108409_bib2","series-title":"Toxoplasma Gondii","first-page":"183","article-title":"Immunological control of Toxoplasma gondii and appropriate vaccine design","author":"Alexander","year":"1996"},{"key":"10.1016\/j.exppara.2022.108409_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.micres.2015.11.006","article-title":"Immunodiagnosis and molecular validation of Toxoplasma gondii-recombinant dense granular (GRA) 7 protein for the detection of toxoplasmosis in patients with cancer","volume":"183","author":"Arab-Mazar","year":"2016","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.exppara.2022.108409_bib5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2307\/1591566","article-title":"Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes","author":"Bounous","year":"1992","journal-title":"Avian Dis."},{"issue":"1","key":"10.1016\/j.exppara.2022.108409_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/CMR.11.1.42","article-title":"Gene therapy for infectious diseases","volume":"11","author":"Bunnell","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.exppara.2022.108409_bib7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fmicb.2016.00609","article-title":"Evaluation of immunoprotection conferred by the subunit vaccines of GRA2 and GRA5 against acute toxoplasmosis in BALB\/c mice","volume":"7","author":"Ching","year":"2016","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.exppara.2022.108409_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0031182000066695","article-title":"Surface antigens of Toxoplasma gondii","volume":"97","author":"Couvreur","year":"1988","journal-title":"Parasitology"},{"issue":"5","key":"10.1016\/j.exppara.2022.108409_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-3024.2008.01025.x","article-title":"Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co\u2010delivery of IL\u201012 in mice","volume":"30","author":"Cui","year":"2008","journal-title":"Parasite Immunol."},{"issue":"11","key":"10.1016\/j.exppara.2022.108409_bib10","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.4049\/jimmunol.149.11.3636","article-title":"Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen","volume":"149","author":"Darcy","year":"1992","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.exppara.2022.108409_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11259-008-9040-3","article-title":"DNA vaccines and their applications in veterinary practice: current perspectives","volume":"32","author":"Dhama","year":"2008","journal-title":"Vet. Res. Commun."},{"issue":"2","key":"10.1016\/j.exppara.2022.108409_bib12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.micinf.2003.11.009","article-title":"The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection","volume":"6","author":"Di Cristina","year":"2004","journal-title":"Microb. Infect."},{"issue":"2","key":"10.1016\/j.exppara.2022.108409_bib13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4049\/jimmunol.175.2.633","article-title":"DNA vaccines: progress and challenges","volume":"175","author":"Donnelly","year":"2005","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.exppara.2022.108409_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.puhe.2007.08.009","article-title":"Congenital toxoplasmosis: priorities for further health promotion action","volume":"122","author":"Elsheikha","year":"2008","journal-title":"Publ. Health"},{"issue":"6","key":"10.1016\/j.exppara.2022.108409_bib16","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.4049\/jimmunol.153.6.2533","article-title":"Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii","volume":"153","author":"Gazzinelli","year":"1994","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.exppara.2022.108409_bib17","first-page":"901","article-title":"Assessment of DNA vaccine encoding Toxoplasma gondii microneme complete gene and IL-12 as adjuvant in BALB\/c mice","volume":"22","author":"Ghaffarifar","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"1","key":"10.1016\/j.exppara.2022.108409_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-7-431","article-title":"DNA vaccination with a gene encoding Toxoplasma gondii Deoxyribose Phosphate Aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice","volume":"7","author":"Hassan","year":"2014","journal-title":"Parasites Vectors"},{"issue":"S2","key":"10.1016\/j.exppara.2022.108409_bib20","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1017\/S0031182006001855","article-title":"Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora","volume":"133","author":"Innes","year":"2006","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2022.108409_bib21","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.ijbiomac.2022.03.146","article-title":"Novel naltrexone hydrochloride nanovaccine based on chitosan nanoparticles promotes induction of Th1 and Th17 immune responses resulting in protection against Toxoplasma gondii tachyzoites in a mouse model","volume":"208","author":"Khorshidvand","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.exppara.2022.108409_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104090","article-title":"Virus-like particle vaccine displaying Toxoplasma gondii apical membrane antigen 1 induces protection against T. gondii ME49 infection in mice","volume":"142","author":"Kim","year":"2020","journal-title":"Microb. Pathog."},{"issue":"38","key":"10.1016\/j.exppara.2022.108409_bib23","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1016\/j.vaccine.2018.08.016","article-title":"Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection","volume":"36","author":"Lee","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2022.108409_bib24","doi-asserted-by":"crossref","DOI":"10.1051\/parasite\/2018040","article-title":"Immunization with plasmid DNA expressing Heat Shock Protein 40 confers prophylactic protection against chronic Toxoplasma gondii infection in Kunming mice","volume":"25","author":"Li","year":"2018","journal-title":"Parasite"},{"issue":"12\u201313","key":"10.1016\/j.exppara.2022.108409_bib25","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.micinf.2008.08.002","article-title":"A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB\/c mice","volume":"10","author":"Liu","year":"2008","journal-title":"Microb. Infect."},{"issue":"5","key":"10.1016\/j.exppara.2022.108409_bib26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0104-4230(11)70117-8","article-title":"Programs for control of congenital toxoplasmosis","volume":"57","author":"Lopes-Mori","year":"2011","journal-title":"Rev. Assoc. M\u00e9d. Bras."},{"issue":"1","key":"10.1016\/j.exppara.2022.108409_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008299","article-title":"T-bet-dependent ILC1-and NK cell-derived IFN-\u03b3 mediates cDC1-dependent host resistance against Toxoplasma gondii","volume":"17","author":"L\u00f3pez-Yglesias","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.exppara.2022.108409_bib28","first-page":"1","article-title":"Toxoplasma gondii vaccine candidates: a concise review","volume":"1971","author":"Mamaghani","year":"2022","journal-title":"Ir. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.exppara.2022.108409_bib29","first-page":"704","article-title":"Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis","volume":"11","author":"Martin","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"1","key":"10.1016\/j.exppara.2022.108409_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpara.2008.08.002","article-title":"The immunobiology of the innate response to Toxoplasma gondii","volume":"39","author":"Miller","year":"2009","journal-title":"Int. J. Parasitol."},{"issue":"9","key":"10.1016\/j.exppara.2022.108409_bib31","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.22572","article-title":"Effect of propranolol alone and in combination with pyrimethamine on acute murine toxoplasmosis","volume":"8","author":"Montazeri","year":"2015","journal-title":"Jundishapur J. Microbiol."},{"key":"10.1016\/j.exppara.2022.108409_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2019.102049","article-title":"T cell-derived interferon-\u03b3 is required for host defense to Toxoplasma gondii","volume":"75","author":"Nishiyama","year":"2020","journal-title":"Parasitol. Int."},{"issue":"12","key":"10.1016\/j.exppara.2022.108409_bib33","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.bios.2005.11.007","article-title":"A rapid highly-sensitive endotoxin detection system","volume":"21","author":"Ong","year":"2006","journal-title":"Biosens. Bioelectron."},{"issue":"9","key":"10.1016\/j.exppara.2022.108409_bib34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.pt.2011.03.009","article-title":"Innate responses to Toxoplasma gondii in mice and humans","volume":"27","author":"Pifer","year":"2011","journal-title":"Trends Parasitol."},{"issue":"4","key":"10.1016\/j.exppara.2022.108409_bib35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1179\/2047773213Y.0000000094","article-title":"Antibiotics for human toxoplasmosis: a systematic review of randomized trials","volume":"107","author":"Rajapakse","year":"2013","journal-title":"Pathog. Glob. Health"},{"issue":"8","key":"10.1016\/j.exppara.2022.108409_bib36","first-page":"785","article-title":"Nucleic acid vaccines: an overview","volume":"15","author":"Robinson","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2022.108409_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/03946320221078436","article-title":"Immune response against toxoplasmosis\u2014some recent updates RH: toxoplasma gondii immune response","volume":"36","author":"Sana","year":"2022","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.exppara.2022.108409_bib38","series-title":"The 17 International and Iranian Congress of Microbiology 23 - 25 August 2016 School of Medicine","article-title":"Comparison interactions between immunogenic epitopes of toxoplasma gondii and mHC cleft in human and sheep using molecular dynamics simulations","author":"Soltani","year":"2016"},{"issue":"12\u201313","key":"10.1016\/j.exppara.2022.108409_bib39","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int. J. Parasitol."},{"issue":"1","key":"10.1016\/j.exppara.2022.108409_bib40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1128\/IAI.68.1.38-45.2000","article-title":"DNA vaccination with genes EncodingToxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice","volume":"68","author":"Vercammen","year":"2000","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.exppara.2022.108409_bib41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4161\/hv.22474","article-title":"Development of Toxoplasma gondii vaccine: a global challenge","volume":"9","author":"Verma","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"issue":"4","key":"10.1016\/j.exppara.2022.108409_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.parint.2007.04.003","article-title":"Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii","volume":"56","author":"Wang","year":"2007","journal-title":"Parasitol. Int."},{"issue":"3","key":"10.1016\/j.exppara.2022.108409_bib43","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.exppara.2008.03.005","article-title":"Comparison of cholera toxin A2\/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine","volume":"119","author":"Xue","year":"2008","journal-title":"Exp. Parasitol."},{"issue":"8","key":"10.1016\/j.exppara.2022.108409_bib44","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.vaccine.2018.12.044","article-title":"Vaccination with recombinant adenoviruses expressing Toxoplasma gondii MIC3, ROP9, and SAG2 provide protective immunity against acute toxoplasmosis in mice","volume":"37","author":"Zhang","year":"2019","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.exppara.2022.108409_bib45","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1586\/14760584.2013.844652","article-title":"Vaccines against Toxoplasma gondii: new developments and perspectives","volume":"12","author":"Zhang","year":"2013","journal-title":"Expet Rev. Vaccine"},{"key":"10.1016\/j.exppara.2022.108409_bib46","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fimmu.2019.00418","article-title":"GRA24-Based DNA vaccine prolongs survival in mice challenged with a virulent toxoplasma gondii strain","volume":"10","author":"Zheng","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.exppara.2022.108409_bib47","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00436-006-0341-6","article-title":"Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris","volume":"100","author":"Zhou","year":"2007","journal-title":"Parasitol. Res."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448942200203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448942200203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:30:42Z","timestamp":1758004242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448942200203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":44,"alternative-id":["S001448942200203X"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2022.108409","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological evaluation of a novel multi-antigenic DNA vaccine encoding SAG1, SAG3, MIC4, GRA5, GRA7, AMA1and BAG1 against Toxoplasma gondii in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2022.108409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108409"}}